ConvaTec Group Plc
OTC: CNVVY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Jonathan Peter Mason
- Employees
- 10,489
- Headquarters
- Reading, United Kingdom
- IPO year
- 2017
- Market cap
- $5.3B
- Website
- https://www.convatecgroup.com
Loading CNVVY…
Loading profile data…Frequently asked questions about CNVVY
What does ConvaTec Group Plc (CNVVY) do?
ConvaTec Group Plc operates as a global medical technology enterprise, specializing in the development, manufacturing, and distribution of a wide range of healthcare products. The company offers advanced wound care and skin protection solutions, tailored for the effective management of both acute and chronic wounds arising from diverse condition...
Where does CNVVY trade?
ConvaTec Group Plc (CNVVY) trades on the Other OTC.
What sector is CNVVY in?
ConvaTec Group Plc (CNVVY) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of ConvaTec Group Plc?
Jonathan Peter Mason is the chief executive officer of ConvaTec Group Plc (CNVVY).
Where is ConvaTec Group Plc headquartered?
ConvaTec Group Plc is headquartered in United Kingdom.
Does CNVVY pay a dividend?
Yes — ConvaTec Group Plc (CNVVY) paid a trailing twelve-month dividend of USD 0.29 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CNVVY go public?
ConvaTec Group Plc (CNVVY) completed its initial public offering in 2017.
Is CNVVY an ADR?
Yes — CNVVY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. ConvaTec Group Plc reporting and dividends follow the underlying issuer.